Jansen, R. et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J. Clin. Microbiol. 49, 2631–2636 (2011).
Rhedin, S. et al. Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics 133, e538–e545 (2014).
Byington, C. L. et al. Community surveillance of respiratory viruses among families in the Utah better identification of germs-longitudinal viral epidemiology (BIG-LoVE) study. Clin. Infect. Dis. 61, 1217–1224 (2015).
Relman, D. A. New technologies, human-microbe interactions, and the search for previously unrecognized pathogens. J. Infect. Dis. 186, 254–258 (2002).
Iroh Tam, P., Bernstein, E., Ma, X. & Ferrieri, P. Blood culture in evaluation of pediatric community-acquired pneumonia: a systematic review and meta-analysis. Hosp. Pediatr. 5, 324–336 (2015).
Van Den Bruel, A. et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ 342, d3082 (2011).
Huang, D. T. et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N. Engl. J. Med. 379, 236–249 (2018).
Engelmann, I. et al. Diagnosis of viral infections using myxovirus resistance protein A (MxA). Pediatrics 135, e985–e993 (2015).
Rhedin, S. et al. Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children: the TREND study. Clin. Microbiol. Infect. 28, 1251–1257 (2022).
Piri, R. et al. Myxovirus resistance protein A as a marker of viral cause of illness in children hospitalized with an acute infection. Microbiol. Spectr. 10, e0203121 (2022).
Piri, R. et al. Evaluation of a novel point-of-care blood myxovirus resistance protein A measurement for the detection of viral infection at the pediatric emergency department. J. Infect. Dis. https://doi.org/10.1093/infdis/jiae367 (2024).
Herberg, J. A. et al. Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children. JAMA 316, 835–845 (2016).
Mahajan, P. et al. Association of RNA biosignatures with bacterial infections in febrile infants aged 60 days or younger. JAMA 316, 846–857 (2016).
Kaforou, M., Herberg, J. A., Wright, V. J., Coin, L. J. M. & Levin, M. Diagnosis of bacterial infection using a 2-transcript host RNA signature in febrile infants 60 days or younger. JAMA 317, 1577–1578 (2017).
Ramilo, O. et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066–2077 (2007).
Zaas, A. K. et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6, 207–217 (2009).
Hu, X., Yu, J., Crosby, S. D. & Storch, G. A. Gene expression profiles in febrile children with defined viral and bacterial infection. Proc. Natl. Acad. Sci. USA 110, 12792–12797 (2013).
Sweeney, T. E., Wong, H. R. & Khatri, P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci. Transl. Med. 8, 346ra91 (2016).
Sampson, D. L. et al. A four-biomarker blood signature discriminates systemic inflammation due to viral infection versus other etiologies. Sci. Rep. 7, 1–17 (2017).
Lydon, E. C. et al. Validation of a host response test to distinguish bacterial and viral respiratory infection. EBioMedicine 48, 453–461 (2019).
Tsalik, E. L. et al. Discriminating bacterial and viral infection using a rapid host gene expression test. Crit. Care Med. 49, 1651–1663 (2021).
Habgood-Coote, D. et al. Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature. Med 4, 635–654 (2023).
Rao, A. M. et al. A robust host-response-based signature distinguishes bacterial and viral infections across diverse global populations. Cell Rep. Med. 3, 100842 (2022).
Ravichandran, S. et al. VB10, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections. EBioMedicine 67, 103352 (2021).
Toivonen, L. et al. Blood MxA protein as a marker for respiratory virus infections in young children. J. Clin. Virol. 62, 8–13 (2015).
Toivonen, L. et al. Rhinovirus infections in the first 2 years of life. Pediatrics 138, e20161309 (2016).
Katayama, S. et al. Guide for library design and bias correction for large-scale transcriptome studies using highly multiplexed RNAseq methods. BMC Bioinform. 20, 1–9 (2019).
Ezer, S. et al. Generation of RNA sequencing libraries for transcriptome analysis of globin-rich tissues of the domestic dog. STAR Protoc. 2, 100995 (2021).
Krjutškov, K. et al. Single-cell transcriptome analysis of endometrial tissue. Hum. Reprod. 31, 844–853 (2016).
Katayama, S., Töhönen, V., Linnarsson, S. & Kere, J. SAMstrt: statistical test for differential expression in single-cell transcriptome with spike-in normalization. Bioinformatics 29, 2943–2945 (2013).
Erkeller-Yuksel, F. M. et al. Age-related changes in human blood lymphocyte subpopulations. J. Pediatr. 120, 216–222 (1992).
Wong, H. R. et al. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit. Care Med. 37, 1558–1566 (2010).
Huang, L., Qiao, L., Zhu, H., Jiang, L. & Yin, L. Genomics of neonatal sepsis: has-miR-150 targeting BCL11B functions in disease progression. Ital. J. Pediatr. 44, 145 (2018).
Ming, T. et al. Integrated analysis of gene co-expression network and prediction model indicates immune-related roles of the identified biomarkers in sepsis and sepsis-induced acute respiratory distress syndrome. Front. Immunol. 13, 897390 (2022).
Herberg, J. A. et al. Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes. J. Infect. Dis. 208, 1664–1668 (2013).
Batarseh, A. & Papadopoulos, V. Regulation of translocator protein 18kDa (TSPO) expression in health and disease states. Mol. Cell. Endocrinol. 327, 1–12 (2010).
Papadopoulos, V. et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402–409 (2006).
Betlazar, C., Middleton, R. J., Banati, R. & Liu, G. J. The translocator protein (TSPO) in mitochondrial bioenergetics and immune processes. Cells 9, 512 (2020).
Blevins, L. K., Crawford, R. B., Azzam, D. J., Guilarte, T. R. & Kaminski, N. E. Surface translocator protein 18 kDa (TSPO) localization on immune cells upon stimulation with LPS and in ART-treated HIV+ subjects. J. Leukoc. Biol. 110, 123–140 (2021).
Veenman, L., Shandalov, Y. & Gavish, M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J. Bioenerg. Biomembr. 40, 199–205 (2008).
Banati, R. B. et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun. 5, 5452 (2014).
Rupprecht, R. et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971–988 (2010).
Colasanti, A. et al. In vivo assessment of brain white matter inflammation in multiple sclerosis with 18F-PBR111 PET. J. Nucl. Med. 55, 1112–1118 (2014).
Hatori, A. et al. PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa). PLoS ONE 7, e45065 (2012).
Giridharan, V. V. et al. A crosstalk between gut and brain in sepsis-induced cognitive decline. J. Neuroinflammation 19, 114 (2022).
Giga, H. et al. Pharmacological and genetic inhibition of translocator protein 18 kDa ameliorated neuroinflammation in murine endotoxemia model. Shock 56, 142–149 (2021).
Jin, G. lin et al. Koumine regulates macrophage M1/M2 polarization via TSPO, alleviating sepsis-associated liver injury in mice. Phytomedicine 107, 154484 (2022).
Leaver, K. R. et al. Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum. ACS Chem. Neurosci. 3, 114–119 (2012).
Barron, A. M. et al. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease. J. Neurosci. 33, 8891–8897 (2013).
Simon-O’Brien, E., Gauthier, D., Riban, V. & Verleye, M. Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury. J. Neuroinflammation 13, 203 (2016).
Leva, G. et al. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 3016–3027 (2017).
Ma, B. et al. Translocator protein agonist Ro5-4864 alleviates neuropathic pain and promotes remyelination in the sciatic nerve. Mol. Pain 14, 1744806917748019 (2018).
Monga, S., Nagler, R., Amara, R., Weizman, A. & Gavish, M. Inhibitory effects of the two novel TSPO ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced microglial activation. Cells 8, 486 (2019).
Dominguini, D. et al. The protective effect of PK-11195 on cognitive impairment in rats survived of polymicrobial sepsis. Mol. Neurobiol. 58, 2724–2733 (2021).
Copeland, P. R., Fletcher, J. E., Carlson, B. A., Hatfield, D. L. & Driscoll, D. M. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J. 19, 306–314 (2000).
Rayman, M. P. Selenium and human health. Lancet 379, 1256–1268 (2012).
Avery, J. C. & Hoffmann, P. R. Selenium, selenoproteins, and immunity. Nutrients 10, 1203 (2018).
Guillin, O. M., Vindry, C., Ohlmann, T. & Chavatte, L. Selenium, selenoproteins and viral infection. Nutrients 11, 2101 (2019).
Fairweather-Tait, S. J. et al. Selenium in human health and disease. Antioxid. Redox Signal. 14, 1337–1383 (2011).
Bae, M. & Kim, H. Mini-review on the roles of vitamin C, vitamin D, and selenium in the immune system against COVID-19. Molecules 25, 5346 (2020).
Hoffmann, F. K. W. et al. Dietary selenium modulates activation and differentiation of CD4+ T cells in mice through a mechanism involving cellular free thiols. J. Nutr. 140, 1155–1161 (2010).
Kiremidjian-Schumacher, L., Roy, M., Harvey, W., Martin, C. & Stotzky, G. Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol. Trace Elem. Res. 41, 103–104 (1994).
Beck, M. et al. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J. 15, 1481–1483 (2001).
Beck, M. A. et al. Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 43, 166–170 (1994).
Moghaddam, A. et al. Selenium deficiency is associated with mortality risk from COVID-19. Nutrients 12, 1–13 (2020).
Khan, M., Dilawar, S., Ali, I. & Rauf, N. The possible role of selenium concentration in hepatitis B and C patients. Saudi J. Gastroenterol. 18, 106–110 (2012).
Stone, C. A., Kawai, K., Kupka, R. & Fawzi, W. W. Role of selenium in HIV infection. Nutr. Rev. 68, 671–681 (2010).
Bodkin, N. et al. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination. Genome Med. 14, 1–14 (2022).
Ko, E. R. et al. Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance. Sci. Rep. 13, 22554 (2023).
Ko, E. R. et al. Prospective validation of a rapid host gene expression test to discriminate bacterial from viral respiratory infection. JAMA Netw. Open 5, e227299 (2022).
Barral-Arca, R., Pardo-Seco, J., Martinón-Torres, F. & Salas, A. A 2-transcript host cell signature distinguishes viral from bacterial diarrhea and it is influenced by the severity of symptoms. Sci. Rep. 8, 4–10 (2018).
Pennisi, I. et al. Discrimination of bacterial and viral infection using host-RNA signatures integrated in a lab-on-chip platform. Biosens. Bioelectron. 216, 114633 (2022).
Shah, P. et al. Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study. Lancet Reg. Health Eur. 26, 100682 (2023).
